.... Prostate carcinoma Internet Guidelines Accordance Information behavior Information seeking An increasing number of patients are screening the internet for information on their disease [ 1 ]. As PCa displays the second most common malignancy worldwide, it seems logical that PCa is one...

... resistance Infection Prostate biopsy Prostate cancer Prostate carcinoma Transrectal ultrasonography Urinary tract infection Abstract Objective: The objective of this study was to determine the prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided...

...K. Gyftopoulos; K. Vourda; G. Sakellaropoulos; P. Perimenis; A. Athanasopoulos; E. Papadaki Objective: Angiogenesis is essential for tumor growth and metastasis; however, angiogenic factors are not uniformly expressed in prostate carcinoma. Our aim was to determine the expression of vascular...

... Tulunayb Orhan Gdgu$'d Departments of a Urology and b Pathology, University of Ankara School of Medicine, Ankara, Turkey Immunohistochemical Determination of p53 Protein in Prostatic Cancer and Prostatic Intraepithelial Neoplasms Key Words p53 Tumor suppressor gene Immunohistochemistry Prostate carcinoma...

... cancer. J Urol 1988:139:758-761. 14 Pontes JE. Eisenkraft S. Watanabe H. Ohe H, Saitoh M. Murphy GP: Preoperative evalua­ tion of localized prostatic carcinoma by transreclal ultrasonography. J Urol 1985; 134:289 291. 15 l.ec F. Torp-Pcderscn ST. Littrup PJ, McLeary RD, McHugh TA, Smid AP. Stella PJ...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Malignant priapism Prostate carcinoma Diagnostics Case Report Urol Int 1994;52:52-54 I. Schroeder-Printzena R...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Mouse monoclonal antibody Prostate carcinoma...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate Prostate carcinoma Prostate neoplasm Case Report Urol Int 1994;52:48-51 NarendraA. Jadeja Prem Nath Dogra...

... RB gene p53gene Tumour progression Prognosis Bladder carcinoma Prostate carcinoma Urological tumours 19 07 1993 9 12 1993 3 2 2010 © 1994 S. Karger AG, Basel 1994 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may...

... subjective improvement for 2 months. However, during the 3rd month of treatment there was global deterioration which progressed further till his demise during the 4th month. The beneficial role, if any, of combined hormonal and immunotherapy in advanced prostatic carcinoma is discussed as also the natural...

... to attain further improvement of the actuarial survival in metastatic prostate carcinoma. 23 04 1987 29 04 1987 2 2 2010 © 1987 S. Karger AG, Basel 1987 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other...

... to in the content or advertisements. Prostate carcinoma Stage T 0b , T 1 + T 2 , T 3 Nonradical prostatectomy Urol. int. 42: 49-52 (1987) >1987 S. Kargcr AG, Basel 0042-1138/87/0421-0049S2.75/0 Cancer of the Prostate: Is There a Need for Aggressive Treatment? Boaz Moskovitz, Sami Nitecki, Dan Richter...

...Boaz Moskovitz; Hedviga Kerner; Dan Richter Levin In 1 out of 56 patients, orchiectomized in the course of treatment for prostatic carcinoma, metastatic growth in the testis was found. This uncommon metastatic spread is a sign of advanced disease. © 1987 S. Karger AG, Basel 1987 Copyright...

... increase in the survival rate during treatment of unconfined metastasizing prostate carcinomas. Even in early stages specific immunotherapy constitutes a new alternative therapeutic method, particularly in the treatment of hormone-independent prostate carcinomas and in cases of estrogen intolerance. Urol...

... in prostatic carcinoma, chemotherapy can be of some usefulness in urology, either alone or in addition to surgery and radiotherapy. The experience is still limited, due to the fact that chemotherapy is not a specific treatment against cancer but, by a generalized cytotoxicity on cells in the reproductive cycle...

... and Unaltered Total Ghrelin and Obestatin Concentrations in Prostate Carcinoma Witold Malendowicza Agnieszka Ziolkowskab Marta Szyszkab Zbigniew Kwiasa Departments of aUrology and Urooncology and bHistology and Embryology, Poznan University of Medical Sciences, Poznan, Poland Key Words Benign prostate...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate carcinoma Transitional...

.... The bcl 2 expression was a characteristic of the tumors of patients who later died. These results show that the degree of induction of apoptosis in prostate carcinoma by hormonal therapy varies from case to case. A given prostate cancer patient’s response to therapy may be predicted by following apoptotic...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate carcinoma Prostate-specific antigen Malignant pleural effusion Gordon A. Brown Phillip C. Ginsberg Richard C. Harkaway Albert Einstein Medical Center...